About Synaptogenix, Inc. 
Synaptogenix, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (1.06%)
Foreign Institutions
Held by 4 Foreign Institutions (0.08%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
Pharmaceuticals & Biotechnology
USD 22 Million ()
NA (Loss Making)
NA
0.00%
-1.05
-39.79%
1.22






